Clinical Trials in New York

Showing 6721-6740 of 17,259 trials

A Study of PRT2527 in Participants With Advanced Solid Tumors

NCT05159518

This is a Phase 1 dose-escalation and confirmation study of PRT2527, a Cyclin-dependent Kinase 9 (CDK9) inhibitor, in participants with advanced solid tumors. The purpose of this study is to define the dosing schedule, and maximally tolerated dose to be used in subsequent development of PRT2527.

SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more

Prelude Therapeutics30 participantsStarted Feb 2022

Denver, Colorado, United States • Celebration, Florida, United States • Sarasota, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

NCT03905330

The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric participants with Progressive Familial Intrahepatic Cholestasis (PFIC).

Progressive Familial Intrahepatic Cholestasis (PFIC)

Mirum Pharmaceuticals, Inc.93 participantsStarted Jul 2019

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Orlando, Florida, United States +28 more locations

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Find Trials by Condition in New York

Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Straberi Epistamp Needling Treatment For Skin Rejuvenation

Straberi Microneedling For Atrophic Acne

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Straberi Epistamp Device for Postinflammatory Hyperpigmentation

HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Unwinding Anxiety for Migraine: Pilot

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Approaches and Decisions for Acute Pediatric TBI Trial

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Adaptive RadioTherapy for OroPharynx Cancer

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

International Lung Screen Trial (ILST)